영업 이익 변화 날짜
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Eli Lilly USD 12.46B 2.68B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD -707.47M 1.41B 2026-09
Insmed USD -81.83M 19.48M 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
Moderna USD 130M 945M 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 662M 5M 2026-09
PTC Therapeutics USD 148.98M 103.09M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 4.72B 2.34B 2026-09
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Tectonic Therapeutic USD -24.22M 3.08M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09